De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer

被引:0
作者
Lorena Gonzalez
Joanne Mortimer
Laura Kruper
机构
[1] City of Hope National Medical Center,Department of Surgery, Division of Breast Surgery
[2] City of Hope National Medical Center,Department of Medical Oncology
来源
Current Breast Cancer Reports | 2021年 / 13卷
关键词
Systemic chemotherapy; Her2+ breast cancer; Triple-negative breast cancer; T1a,bN0;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:151 / 156
页数:5
相关论文
共 447 条
[1]  
Fracheboud J(1998)Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening Int J Cancer 75 694-698
[2]  
Berry DA(2005)Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 1784-1792
[3]  
Cronin KA(2007)Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma J Clin Oncol 25 4952-4960
[4]  
Plevritis SK(1993)Insights into breast cancer screening of younger women. Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project Cancer 72 1449-1456
[5]  
Fryback DG(2010)A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment? Breast Cancer Res Treat 119 653-661
[6]  
Clarke L(2018)Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer N Engl J Med 379 111-121
[7]  
Zelen M(2006)Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 3726-3734
[8]  
Mandelblatt JS(2014)Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study J Clin Oncol 32 2142-2150
[9]  
Yakovlev AY(2005)Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673-1684
[10]  
Habbema JDF(2005)Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659-1672